Cargando…
Sirtuin 1 knockdown inhibits glioma cell proliferation and potentiates temozolomide toxicity via facilitation of reactive oxygen species generation
Malignant glioma is one of the most common types of primary malignancies in the human central nervous system. Temozolomide (TMZ) is the most commonly used drug in clinical therapy of glioma; however, chemoresistance makes glioma difficult to cure and relapse likely. Sirtuin 1 (SIRT1) serves importan...
Autores principales: | Chen, Hongwu, Lin, Rui, Zhang, Ziheng, Wei, Quantang, Zhong, Zhiwei, Huang, Jiehao, Xu, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507466/ https://www.ncbi.nlm.nih.gov/pubmed/31186751 http://dx.doi.org/10.3892/ol.2019.10235 |
Ejemplares similares
-
Downregulation of LKB1 promotes tumor progression and predicts unfavorable prognosis in patients with glioma
por: Huang, Jiehao, et al.
Publicado: (2017) -
Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide
por: Yan, Tao, et al.
Publicado: (2011) -
Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy
por: Jiang, Pengfei, et al.
Publicado: (2016) -
Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux
por: Wen, Zhi-peng, et al.
Publicado: (2019) -
Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
por: Lv, Qiao-Li, et al.
Publicado: (2020)